L. Bras, J. Musset, L. Clain, and J. , Les r??sistances aux??m??dicaments antipaludiques, M??decine et Maladies Infectieuses, vol.36, issue.8, pp.401-405, 2006.
DOI : 10.1016/j.medmal.2006.05.005

F. Smithuis, M. Kyaw, O. Phe, K. Aye, L. Htet et al., Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison, The Lancet, vol.367, issue.9528, pp.2075-2085, 2006.
DOI : 10.1016/S0140-6736(06)68931-9

N. Thang, T. Trung, N. Phong, H. Quang, B. Dai et al., The efficacy and tolerability of artemisinin-piperaquine (Artequick) versus artesunate-amodiaquine (Coarsucam) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam, Malar J, vol.11, p.217, 2012.

W. Yavo, F. B. Kuete, T. Djohan, V. Oga, S. Kassi et al., Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa, Malaria Journal, vol.10, issue.1, p.198, 2011.
DOI : 10.1016/j.trstmh.2007.05.018

A. Yeka, J. Tibenderana, J. Achan, D. 'alessandro, U. Talisuna et al., Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children, PLoS ONE, vol.379, issue.9, p.53772, 2013.
DOI : 10.1371/journal.pone.0053772.s005

A. Yeka, G. Dorsey, M. Kamya, A. Talisuna, M. Lugemwa et al., Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda, PLoS ONE, vol.360, issue.6, p.2390, 2008.
DOI : 10.1371/journal.pone.0002390.s002

M. Kamya, A. Yeka, H. Burkirwa, M. Lugemwa, J. Rwakimari et al., Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial, PLoS Clinical Trials, vol.2, issue.5, p.20, 2007.
DOI : 10.1371/journal.pctr.0020020.sd002

I. Zongo, G. Dorsey, N. Rouamba, C. Dokomajilar, Y. Séré et al., Randomized Comparison of Amodiaquine plus Sulfadoxine-Pyrimethamine, Artemether-Lumefantrine, and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Burkina Faso, Clinical Infectious Diseases, vol.45, issue.11, pp.1453-1461, 2007.
DOI : 10.1086/522985

A. Hasugian, H. Purba, E. Kenangalem, R. Wuwung, E. Ebsworth et al., Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax Malaria, Clinical Infectious Diseases, vol.44, issue.8, pp.1067-1074, 2008.
DOI : 10.1086/512677

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532501

T. Davis, T. Hung, I. Sim, H. Karunajeewa, and K. Ilett, Piperaquine, Drugs, vol.7, issue.1, pp.75-87, 2005.
DOI : 10.2165/00003495-200565010-00004

M. Hao, D. Jia, Q. Li, Y. He, L. Yuan et al., In Vitro Sensitivities of Plasmodium falciparum Isolates from the China-Myanmar Border to Piperaquine and Association with Polymorphisms in Candidate Genes, Antimicrobial Agents and Chemotherapy, vol.57, issue.4, pp.1723-1729, 2013.
DOI : 10.1128/AAC.02306-12

R. Wong, D. Lautu, L. Tavul, S. Hackett, P. Siba et al., to conventional and novel antimalarial drugs in Papua New Guinea, Tropical Medicine & International Health, vol.2, issue.Suppl. 4, pp.342-349, 2010.
DOI : 10.1111/j.1365-3156.2009.02463.x

L. Basco and P. Ringwald, In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon, Antimicrobial Agents and Chemotherapy, vol.47, issue.4, pp.1391-1394, 2003.
DOI : 10.1128/AAC.47.4.1391-1394.2003

S. Nsobya, M. Kiggundu, S. Nanyunja, M. Joloba, B. Greenhouse et al., In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1200-1206, 2010.
DOI : 10.1128/AAC.01412-09

L. Mwai, S. Kiara, A. Abdirahman, L. Pole, A. Rippert et al., In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1, Antimicrobial Agents and Chemotherapy, vol.53, issue.12, pp.5069-5073, 2009.
DOI : 10.1128/AAC.00638-09

S. Briolant, M. Henry, C. Oeuvray, R. Amalvict, E. Baret et al., Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3537-3544, 2010.
DOI : 10.1128/AAC.00183-10

A. Pascual, P. Parola, F. Benoit-vical, F. Simon, D. Malvy et al., Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum, Malaria Journal, vol.11, issue.1, p.45, 2012.
DOI : 10.1128/AAC.49.12.5127-5128.2005

URL : https://hal.archives-ouvertes.fr/pasteur-00836167

. Fidockda, . Nomurat, . Talleyak, . Cooperra, . Dzekunovsm et al., Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance, Molecular Cell, vol.6, issue.4, pp.861-871, 2000.
DOI : 10.1016/S1097-2765(05)00077-8

C. Lambros and J. Vanderberg, Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture, The Journal of Parasitology, vol.65, issue.3, pp.418-420, 1979.
DOI : 10.2307/3280287

H. Bogreau, F. Renaud, H. Bouchiba, P. Durand, S. Assi et al., Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-959, 2006.

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-151, 2006.

H. Tinto, J. Ouédraogo, E. A. Van-overmeir, C. Dujardin, J. Van-marck et al., Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa, vivo chloroquine resistance in Burkina Faso, pp.287-292, 2003.
DOI : 10.1016/j.meegid.2003.08.002

M. Barends, A. Jaidee, N. Khaohirun, P. Singhasivanon, and F. Nosten, In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border, Malaria Journal, vol.6, issue.1, p.81, 2007.
DOI : 10.1186/1475-2875-6-81

J. Marfurt, F. Chalfein, P. Prayoga, F. Wabiser, E. Kenangalem et al., Ex Vivo Drug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax, Antimicrobial Agents and Chemotherapy, vol.55, issue.9, pp.4461-4464, 2011.
DOI : 10.1128/AAC.01375-10

L. Basco and P. Ringwald, Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum

M. Duraisingh, C. Drakeley, O. Muller, R. Bailey, G. Snounou et al., Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine, Parasitology, vol.114, issue.3, pp.205-211, 1997.
DOI : 10.1017/S0031182096008487

S. Foote, D. Kyle, R. Martin, A. Oduola, K. Forsyth et al., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, vol.345, issue.6272, pp.255-258, 1990.
DOI : 10.1038/345255a0

M. Grobusch, I. Adagu, P. Kremsner, and D. Warhurst, Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon, Parasitology, vol.116, issue.3, pp.211-217, 1998.
DOI : 10.1017/S0031182097002266

S. Muangnoicharoen, D. Johnson, S. Looareesuwan, S. Krudsood, and S. Ward, Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro, Antimicrobial Agents and Chemotherapy, vol.53, issue.4, pp.1362-1366, 2009.
DOI : 10.1128/AAC.01656-08

R. Eastman, N. Dharia, E. Winzeler, and D. Fidock, Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured Plasmodium falciparum Parasites, Antimicrobial Agents and Chemotherapy, vol.55, issue.8, pp.3908-3916, 2011.
DOI : 10.1128/AAC.01793-10